Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary Obagi Medical Products collaborated with Nextcell Medical Company to claim exclusive distribution of Suzan Obagi, MD’s line of skin care products throughout the United States.
Established in 2013 with cosmetic surgeon and dermatologist, Suzan Obagi, MD, Nextcell Medical has been working on innovations to change the industry’s approach to skin care. According to the company, Obagi intends to continue to invest in Nextcell’s research and development efforts.
“I am so excited to finally unveil my line alongside the Obagi line of products,” said Dr. Suzan Obagi. “We have been working long and hard on designing a new concept of skin care for the modern patient. With our visions aligned, I can’t think of a better company than Obagi to introduce our products.”
“The relationship between Obagi and Nextcell is a forward move for this important brand,” said Joseph C. Papa, Chairman and CEO of Valeant. “Dr. Suzan Obagi brings extensive academic and clinical experience to the rich history of Obagi.”
“We are thrilled to have the opportunity to work with Obagi and continue to build on the brand’s already strong reputation and unsurpassed brand recognition,” stated Mazen F. Youssef, President and CEO of Nextcell. “We are confident our collaboration will accelerate the growth of both companies and complete Obagi’s portfolio with Dr. Obagi’s novel innovations.”
The US launch of Suzan Obagi, MD’s line for Obagi is anticipated for mid-year of 2017.